The Future of Weight Loss: Combining ESG and GLP-1
Obesity is a complex, chronic metabolic disease affecting 42% of the adult population in the United States alone. As this [...]
22 05, 2026
6 04, 2026
The GLP-1 Struggle: Daily Fatigue & Side Effects
Are you watching the scale stay stubbornly still despite weekly injections? For many, the initial magic of GLP-1 medications like [...]
27 03, 2026
Metabolic Bariatric Surgery vs. GLP-1 Receptor Agonists for Obesity Management
This Systematic Review and Meta-Analysis examines two leading treatments for obesity: surgical intervention and pharmacological therapy using GLP-1 receptor agonists. [...]
11 02, 2026
The GLP-1 Trap: Your Jumpstart Might Be a Forever Commitment
The marketing for GLP-1 agonists such as Ozempic, Wegovy, and Mounjaro is ubiquitous. From glossy telehealth ads to celebrity endorsements from stars like Serena [...]
13 12, 2024
Why Choose Bariatric Surgery Over Ozempic: Real Stories
Millions turn to Ozempic for their weight-loss journey, drawn in by its promise of quick results. But for some, the [...]
26 08, 2016
The Potential Dangers of Weight Loss Pills Exposed
For many of us, fighting obesity is an all-out war. You may win a few battles, but the slightest [...]